Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The C1R cell line has a defined endogenous peptide repertoire resulting from low levels HLA B*35:03 and normal levels of HLA C*04:01 (ref. 3 ); moreover these cells are able to support high-level expression of individually transfected HLA-A, HLA-B or HLA-C gene products 74 .”
From Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics (2019) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Semi-supervised learning for peptide identification from shotgun proteomics datasets
Käll, L., Canterbury, J. D., Weston, J., Noble, W. S., & MacCoss, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1113 · Cited by 2,424
Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry
Syka, J. E. P., Coon, J. J., Schroeder, M. J., Shabanowitz, J., & Hunt, D. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402700101 · Cited by 2,370
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044 · cited 1×
“Human Leukocyte Antigen (HLA)(1) class II molecules on professional antigen presenting cells such as dendritic cells (DC) expose peptide fragments derived from exogenous and endogenous proteins to be screened by CD4 T cells (1, 2).”
BackgroundAutophagy in infection, inflammation and immunity
Deretic, V., Saitoh, T., & Akira, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3532 · Cited by 1,919
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
Vizcaíno, J. A., Côté, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1262 · Cited by 1,918
The ins and outs of MHC class II-mediated antigen processing and presentation
Roche, P. A., & Furuta, K. (2015) · Nature reviews. Immunology · doi:10.1038/nri3818 · Cited by 1,207
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
Milner, E., Barnea, E., Beer, I., & Admon, A. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500241-mcp200 · Cited by 122
Research works printed but not linked: 67
- Adamopoulou, 2013, Exploring the MHC-peptide matrix of central tolerance in the human thymus, Nat. Commun, 4, 2039, 10.1038/ncomms3039 · DOI · Paper page
- Suri, 2006, The wide diversity and complexity of peptides bound to class II MHC molecules, Curr. Opin. Immunol, 18, 70, 10.1016/j.coi.2005.11.002 · DOI
- Ovsyannikova, 2007, Mass spectrometry and peptide-based vaccine development, Clin. Pharmacol. Ther, 82, 644, 10.1038/sj.clpt.6100389 · DOI
- Thibodeau, 2012, Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy, Oncoimmunology, 1, 908, 10.4161/onci.21205 · DOI · Paper page
- Purcell, 2004, Isolation and characterization of naturally processed MHC-bound peptides from the surface of antigen-presenting cells, Methods Mol. Biol, 251, 291
- Lippolis, 2002, Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets, J. Immunol, 169, 5089, 10.4049/jimmunol.169.9.5089 · DOI · Paper page
- Dengjel, 2005, Autophagy promotes MHC class II presentation of peptides from intracellular source proteins, Proc. Natl. Acad. Sci. U.S.A, 102, 7922, 10.1073/pnas.0501190102 · DOI · Paper page
- Münz, 2012, Antigen processing for MHC class II presentation via autophagy, Front. Immunol, 3, 1, 10.3389/fimmu.2012.00009 · DOI
- Stenger, 2014, Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells, Clin. Vaccine Immunol, 21, 641, 10.1128/CVI.00665-13 · DOI
- Bergseng, 2014, Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires, Immunogenetics, 67, 73, 10.1007/s00251-014-0819-9 · DOI · Paper page
- Depontieu, 2009, Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy, Proc. Natl. Acad. Sci. U.S.A, 106, 12073, 10.1073/pnas.0903852106 · DOI · Paper page
- Benham, 2015, Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients, Sci. Transl. Med, 7, 290ra87, 10.1126/scitranslmed.aaa9301 · DOI · Paper page
- Fissolo, 2009, Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients, Mol. Cell. Proteomics, 8, 2090, 10.1074/mcp.M900001-MCP200 · DOI
- Hill, 2003, Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule, J. Immunol, 171, 538, 10.4049/jimmunol.171.2.538 · DOI · Paper page
- Chornoguz, 2012, Major Histocompatibility Complex Class II+ Invariant Chain Negative Breast Cancer Cells Present Unique Peptides That Activate Tumor-specific T Cells From Breast Cancer Patients, Mol. Cell. Proteomics, 1457, 10.1074/mcp.M112.019232 · DOI
- Dengjel, 2004, Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry, Eur. J. Immunol, 34, 3644, 10.1002/eji.200425510 · DOI
- Collado, 2013, Composition of the HLA-DR-associated human thymus peptidome, Eur. J. Immunol, 43, 2273, 10.1002/eji.201243280 · DOI
- Granados, 2015, The nature of self for T cells—a systems-level perspective, Curr. Opin. Immunol, 34, 1, 10.1016/j.coi.2014.10.012 · DOI
- van Haren, 2011, HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.002246 · DOI · Paper page
- Masterson, 2002, MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+precursors, Blood, 100, 701, 10.1182/blood.V100.2.701 · DOI · Paper page
- Hoefnagel, 2011, Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity, Vaccine, 29, 5114, 10.1016/j.vaccine.2011.05.050 · DOI
- Hoonakker, 2015, In vitro innate immune cell based models to assess whole cell Bordetella pertussis vaccine quality: a proof of principle, Biologicals, 43, 100, 10.1016/j.biologicals.2014.12.002 · DOI
- Frese, 2012, Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry, Anal. Chem, 84, 9668, 10.1021/ac3025366 · DOI · Paper page
- Meiring, 2006, Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection, Mol. Cell. Proteomics, 5, 902, 10.1074/mcp.T500014-MCP200 · DOI
- Meiring, 2007, Targeted identification of infection-related HLA class I-presented epitopes by stable isotope tagging of epitopes (SITE), Curr. Protoc. Immunol, 10.1002/0471142735.im1603s77 · DOI
- Mommen, 2014, Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD), Proc. Natl. Acad. Sci. U.S.A, 111, 4507, 10.1073/pnas.1321458111 · DOI · Paper page
- Yu, 2014, CELLO2GO: a web server for protein subCELlular LOcalization prediction with functional gene ontology annotation, PLoS ONE, 9, e99368, 10.1371/journal.pone.0099368 · DOI · Paper page
- Karosiene, 2013, NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ, Immunogenetics, 65, 711, 10.1007/s00251-013-0720-y · DOI · Paper page
- Andreatta, 2013, Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach, Bioinformatics, 29, 8, 10.1093/bioinformatics/bts621 · DOI
- Colaert, 2009, Improved visualization of protein consensus sequences by iceLogo, Nat. Methods, 6, 786, 10.1038/nmeth1109-786 · DOI · Paper page
- Bassani-Sternberg, 2015, Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation, Mol. Cell. Proteomics, 14, 658, 10.1074/mcp.M114.042812 · DOI · Paper page
- Impens, 2010, A quantitative proteomics design for systematic identification of protease cleavage events, Mol. Cell. Proteomics, 9, 2327, 10.1074/mcp.M110.001271 · DOI
- Sun, 2013, Proteolytic characteristics of cathepsin D related to the recognition and cleavage of its target proteins, PLoS ONE, 8, e65733, 10.1371/journal.pone.0065733 · DOI
- Nelson, 1997, Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules, Proc. Natl. Acad. Sci. U.S.A, 94, 628, 10.1073/pnas.94.2.628 · DOI
- Larsen, 1996, T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides, J. Exp. Med, 184, 183, 10.1084/jem.184.1.183 · DOI · Paper page
- West, 2004, Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling, Science, 305, 1153, 10.1126/science.1099153 · DOI · Paper page
- Mi, 2013, Large-scale gene function analysis with the PANTHER classification system, Nat. Protoc, 8, 1551, 10.1038/nprot.2013.092 · DOI · Paper page
- Caron, 2015, An open-source computational and data resource to analyze digital maps of immunopeptidomes, Elife, 4, 1, 10.7554/eLife.07661 · DOI
- Seward, 2011, Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.002477 · doi:10.1074/mcp.m110.002477
- Alvarez, 2008, The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB1*0101) and HLA-DR4 (DRB*0401), Arthritis Rheum, 58, 1630, 10.1002/art.23503 · doi:10.1002/art.23503
- Frese, 2013, Profiling of diet-induced neuropeptide changes in rat brain by quantitative mass spectrometry, Anal. Chem, 85, 4594, 10.1021/ac400232y · DOI
- Sasaki, 2013, Large-scale identification of endogenous secretory peptides using electron transfer dissociation mass spectrometry, Mol. Cell. Proteomics, 12, 700, 10.1074/mcp.M112.017400 · DOI
- Frese, 2011, Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos, J. Proteome Res, 10, 2377, 10.1021/pr1011729 · DOI · Paper page
- Mommen, 2014, Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD), Proc. Natl. Acad. Sci. U.S.A, 111, 4507, 10.1073/pnas.1321458111 · DOI · Paper page
- Marino, 2015, Extended O-GlcNAc on HLA Class-I-Bound Peptides, J. Am. Chem. Soc, 10.1021/jacs.5b06586 · DOI · Paper page
- Weinzierl, 2006, Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface, Mol. Cell. Proteomics, 6, 102, 10.1074/mcp.M600310-MCP200 · DOI · Paper page
- Fortier, 2008, The MHC class I peptide repertoire is molded by the transcriptome, J. Exp. Med, 205, 595, 10.1084/jem.20071985 · DOI · Paper page
- Blanco, 2008, Dendritic cells and cytokines in human inflammatory and autoimmune diseases, Cytokine Growth Factor Rev, 19, 41, 10.1016/j.cytogfr.2007.10.004 · DOI · Paper page
- Watts, 2012, The endosome-lysosome pathway and information generation in the immune system, Biochim. Biophys. Acta, 1824, 14, 10.1016/j.bbapap.2011.07.006 · DOI · Paper page
- Chicz, 1993, Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles, J. Exp. Med, 178, 27, 10.1084/jem.178.1.27 · DOI · Paper page
- Rotzschke, 1994, Origin, structure and motifs of naturally processed MHC class II ligands, Curr. Opin. Immunol, 6, 45, 10.1016/0952-7915(94)90032-9 · DOI
- Juncker, 2009, Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands, PLoS ONE, 4, e7448, 10.1371/journal.pone.0007448 · DOI
- Schmid, 2006, Autophagy in innate and adaptive immunity against intracellular pathogens, J. Mol. Med, 84, 194, 10.1007/s00109-005-0014-4 · DOI
- Jaraquemada, 1990, An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells, J. Exp. Med, 172, 947, 10.1084/jem.172.3.947 · DOI · Paper page
- Jacobson, 1989, HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells, J. Virol, 63, 1756, 10.1128/jvi.63.4.1756-1762.1989 · DOI · Paper page
- Li, 2008, Efficient cross-presentation depends on autophagy in tumor cells, Cancer Res, 68, 6889, 10.1158/0008-5472.CAN-08-0161 · DOI · Paper page
- Li, 2011, Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy, Clin. Cancer Res, 17, 7047, 10.1158/1078-0432.CCR-11-0951 · DOI · Paper page
- Wang, 1999, Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen, Science, 284, 1351, 10.1126/science.284.5418.1351 · DOI · Paper page
- Dengjel, 2005, Autophagy promotes MHC class II presentation of peptides from intracellular source proteins, Proc. Natl. Acad. Sci. U.S.A, 102, 7922, 10.1073/pnas.0501190102 · DOI · Paper page
- Münz, 2009, Enhancing immunity through autophagy, Annu. Rev. Immunol, 27, 423, 10.1146/annurev.immunol.021908.132537 · DOI · Paper page
- Crotzer, 2009, Autophagy and its role in MHC-mediated antigen presentation, J. Immunol, 182, 3335, 10.4049/jimmunol.0803458 · DOI · Paper page
- Herberts, 2003, Dynamics of measles virus protein expression are reflected in the MHC class I epitope display, Mol. Immunol, 39, 567, 10.1016/S0161-5890(02)00204-3 · doi:10.1016/s0161-5890(02)00204-3
- Bozzacco, 2011, Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells, J. Proteome Res, 10, 5016, 10.1021/pr200503g · DOI · Paper page
- Yewdell, 2006, Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses, Immunity, 25, 533, 10.1016/j.immuni.2006.09.005 · DOI · Paper page
- Blum, 2013, Pathways of antigen processing, Annu Rev Immunol, 31, 443, 10.1146/annurev-immunol-032712-095910 · DOI · Paper page
- Villadangos, 2005, Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces, Immunol. Rev, 207, 191, 10.1111/j.0105-2896.2005.00317.x · DOI · Paper page
- Novellino, 2003, Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen, J. Immunol, 170, 6363, 10.4049/jimmunol.170.12.6363 · DOI
Cited by
Abelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Purcell, A. W., Ramarathinam, S. H., & Ternette, N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0133-y · Cited by 394
Predicting HLA class II antigen presentation through integrated deep learning
Chen, B., Khodadoust, M. S., Olsson, N., Wagar, L. E., Fast, E., Liu, C. L., Muftuoglu, Y., Sworder, B. J., Diehn, M., Levy, R., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0280-2 · Cited by 314
Metadata
- Authors
- Mommen, G. P. M., Marino, F., Meiring, H. D., Poelen, M. C. M., van Gaans-van den Brink, J. A. M., Mohammed, S., Heck, A. J. R., & van Els, C. A. C. M.
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 15
- Issue
- 4
- Pages
- 1412-1423
- ISSN
- 1535-9476
- Cited by
- 66
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1630 d)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Project Proteins At Work (project 184.032.201), VIDI grant for Shabaz Mohammed (700.10.429))
- Ministerie van Volksgezondheid, Welzijn en Sport (Strategic Research Project Immunoproteomics, Research Project Correlates of Protection)
- Dutch Ministry of Education, Culture and Science (A Gravitation project at the Institute for Chemical Immunology)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.